1[3]Coleman RE, Purohit OP. Osteoclast inhibition for the treatment of bone metastases[J]. Cancer Treat Rev, 1993, 19(1): 79 ～ 103
2[4]Theriault RL, Lipton A, Hortobagyi GN, et al. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lyric bone lesion: a randomized, placebo-controlled trial.Protocol 18 Aredia Breast Cancer Study Group [J].J Clin Oncol,1999, 17(3): 846～854
3[5]Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats [J]. Cancer Res,2002, 62(22): 6538～6544
4[6]Boissier S, Magnetto S, Fraappart L, et al. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices [J]. Cancer Res, 1997,57(18): 3890～3894
5[7]Lipton A, Berenson JR. Bisphosphonate treatment of Lyric bone metastases[J]. Drugs Aging, 1999, 14(4): 241～246
6申淑景 马智勇 李醒亚.博宁引起呼吸困难2例[J].中国新药杂志,1999,8:561-561.
7Boutsen Y, Jamart J, Esselinckx W, et al. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and caicium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.J Bone Miner Res. 2001.16:104-112.
8Morabito N, Gaudio A, Lasco A, et al. Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postemenopausal osteoporosis. Osteoporos Int,2003,14 :500-506.
9Bartram SA, Peaston RT, Rawlings DJ, et al. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Phamacol Ther,2003.18 : 1121-1127.
10Senaratne SG, Pirianov G, Mansi JL. Bisphosphonates induce apoptosis in human breast cancer cell lines. J Pediatr Endocrinol Metab ,2002,15 : 163-174.
